@article{18f9ad09806e4d41a8a4ab5a32376d9e,
title = "Should preimplantation genetic testing for polygenic disease be offered to all – or none?",
author = "Treff, {Nathan R.} and Julian Savulescu and {de Melo-Mart{\'i}n}, Inmaculada and Shulman, {Lee P.} and Feinberg, {Eve C.}",
note = "Funding Information: Author Savulescu reports grants from Wellcome Trust (Grant: WT203132), Australian Government Medical Research Futures Fund (76749), Australian Research Council (LP190100841), Illumina, The Uehiro Foundation on Ethics and Education, World Health Organization, and AHRC/ UKRI; consulting fees from Bayer Pharmaceutical and Avon Cosmetics; royalties from various publishing houses; honoraria from MyProtein, Various University and educational institutions, and Various media outlets; travel support from Various University and educational institutions and Bayer Pharmaceutical. Author Treff reports employee and shareholder in Genomic Prediction. Author de Melo reports northing to disclose. Author Shulman reports consulting fees from Embryome, Natera, and Celula China; medical director for RGI; advisory board for Astellas; ISPD – treasurer. ",
year = "2022",
month = jun,
doi = "10.1016/j.fertnstert.2022.03.017",
language = "English (US)",
volume = "117",
pages = "1162--1167",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "6",
}